2018 annual financial data
Sutro Biopharma 2018 Operating cash flow
Direct answer
Operating cash flow was 12,683,000 USD.
Operating income was -37,223,000 USD and net income was -35,317,000 USD.
Operating cash flow was 12,683,000 USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,419,000 USD
- Operating income
- -37,223,000 USD
- Net income
- -35,317,000 USD
- Operating cash flow
- 12,683,000 USD